M&A Deal Summary |
|
---|---|
Date | 2023-10-05 |
Target | Odyssey Health - Neurological Drug Technology |
Sector | Medical Products |
Buyer(s) | Oragenics |
Sellers(s) | Odyssey Health |
Deal Type | Divestiture |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1996 |
Sector | Life Science |
Employees | 5 |
Revenue | 14M USD (2022) |
Oragenics is a developer of of novel antibiotics against infectious disease and developing effective treatments for oral mucositis. Oragenics was founded in 1996 and is based in Tampa, Florida.
DEAL STATS | # |
---|---|
Overall | 3 of 3 |
Sector (Medical Products) | 1 of 1 |
Type (Divestiture) | 1 of 1 |
State (Nevada) | 1 of 1 |
Country (United States) | 2 of 2 |
Year (2023) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-03-09 |
Biodextris
Laval, Quebec, Canada Biodextris, Inc. is a contract research organization providing a suite of analytical, process development and CMC consulting services for vaccines and biologics in the clinical stages of development. Biodextris is based in Laval, Quebec. |
Buy | - |
Category | Company |
---|---|
Founded | 2014 |
Sector | Medical Products |
Odyssey Health is a medical company with a focus on life-enhancing medical solutions. Odyssey Health was founded in 2014 and is based in Las Vegas, Nevada.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Medical Products) | 1 of 1 |
Type (Divestiture) | 1 of 1 |
State (Nevada) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2023) | 1 of 1 |